Ayurcann Holdings Corp.
AYURF
$0.0175
-$0.0033-15.87%
| Weiss Ratings | AYURF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | AYURF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Fair | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | AYURF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 2.11 | |||
| Price History | AYURF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -15.87% | |||
| 30-Day Total Return | -15.87% | |||
| 60-Day Total Return | 8.02% | |||
| 90-Day Total Return | -20.45% | |||
| Year to Date Total Return | 8.02% | |||
| 1-Year Total Return | -34.70% | |||
| 2-Year Total Return | -53.95% | |||
| 3-Year Total Return | -86.25% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -85.04% | |||
| 52-Week Low % Change | 8.02% | |||
| Price | AYURF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.12 | |||
| 52-Week Low Price | $0.02 | |||
| 52-Week Low Price (Date) | Dec 02, 2024 | |||
| 52-Week High Price (Date) | Jun 27, 2024 | |||
| Valuation | AYURF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 4.08M | |||
| Enterprise Value | 3.87M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.01 | |||
| Earnings Per Share Growth | -46.28% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.16 | |||
| Price/Book (Q) | 29.17 | |||
| Enterprise Value/Revenue (TTM) | 0.19 | |||
| Price | $0.02 | |||
| Enterprise Value/EBITDA (TTM) | -3.22 | |||
| Enterprise Value/EBIT | -1.99 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | AYURF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 194.70M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | AYURF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 905 492 3322 | |||
| Address | 1080 Brock Road Pickering, ON L1W 3X4 | |||
| Website | ayurcann.com | |||
| Country | Canada | |||
| Year Founded | -- | |||
| Profitability | AYURF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -9.30% | |||
| Profit Margin | -12.21% | |||
| Management Effectiveness | AYURF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -10.36% | |||
| Return on Equity | -- | |||
| Income Statement | AYURF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 20.92M | |||
| Total Revenue (TTM) | 20.92M | |||
| Revenue Per Share | $0.11 | |||
| Gross Profit (TTM) | 7.30M | |||
| EBITDA (TTM) | -1.20M | |||
| EBIT (TTM) | -1.95M | |||
| Net Income (TTM) | -2.56M | |||
| Net Income Avl. to Common (TTM) | -2.56M | |||
| Total Revenue Growth (Q YOY) | 25.60% | |||
| Earnings Growth (Q YOY) | 84.68% | |||
| EPS Diluted (TTM) | -0.01 | |||
| EPS Diluted Growth (Q YOY) | 88.57% | |||
| Balance Sheet | AYURF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 926.20K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 9.21M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 115.60K | |||
| Current Ratio (Q) | 1.369 | |||
| Book Value Per Share (Q) | $0.00 | |||
| Total Assets (Q) | 11.24M | |||
| Total Current Liabilities (Q) | 6.73M | |||
| Total Debt (Q) | 715.70K | |||
| Total Liabilities (Q) | 11.12M | |||
| Total Common Equity (Q) | 115.60K | |||
| Cash Flow | AYURF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -18.60K | |||
| Cash from Financing (TTM) | -385.60K | |||
| Net Change in Cash (TTM) | -1.15M | |||
| Levered Free Cash Flow (TTM) | -6.26M | |||
| Cash from Operations (TTM) | -748.60K | |||
